Alnylam: Strong 2022 Prelims, Cash Position

 Achieved Full Year 2022 Preliminary Global Net Product Revenues of $894 Million for ONPATTRO®, AMVUTTRA®, GIVLAARI®, and OXLUMO®, Representing 35% Annual Growth (43% Using Constant Exchange Rate**) –

– Strength of AMVUTTRA Launch Drove 37% Total TTR Annual Revenue Growth –

– Maintained Strong Balance Sheet with Year-End Cash and Investments Balance of Approximately $2.2 Billion –

https://finance.yahoo.com/news/alnylam-announces-preliminary-fourth-quarter-230000243.html